Targeted therapies for cardiac diseases

Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regu...

Full description

Saved in:
Bibliographic Details
Published in:Nature reviews cardiology 2022-06, Vol.19 (6), p.343-344
Main Authors: Maack, Christoph, Tardiff, Jil C.
Format: Article
Language:English
Subjects:
692/420
692/699/75/230
692/700/565
Antineoplastic Agents - therapeutic use
Cancer therapies
Cardiac function
Cardiac Imaging
Cardiac Surgery
Cardiology
Cardiomyopathy
Child development
Comment
Dehydrogenases
Disease
Ejection fraction
Heart attacks
Heart Diseases - drug therapy
Heart failure
Humans
Immune system
Inflammation
Medicine
Medicine & Public Health
Metabolic disorders
Molecular Targeted Therapy
Nervous system
Obesity
Physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53
cites cdi_FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53
container_end_page 344
container_issue 6
container_start_page 343
container_title Nature reviews cardiology
container_volume 19
creator Maack, Christoph
Tardiff, Jil C.
description Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regulatory Mechanisms aims to identify novel treatment targets by applying high-resolution approaches to complex cardiac disorders.
doi_str_mv 10.1038/s41569-022-00704-x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2655563844</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2666124565</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlb_gAdZ8KCX1cnn7h6l-AUFL_UcYjKpW9puTXah_ntTt1bw4GkG5pl3hoeQcwo3FHh5GwWVqsqBsRygAJFvDsiQFrLKJVA43PfABuQkxjmAEoXkx2TApVBlVZVDcjU1YYYtuqx9x2DWNcbMNyGzJrja2MzVEU3EeEqOvFlEPNvVEXl9uJ-On_LJy-Pz-G6SW17INhcODXeytKAs5Qq5soqWhTElrRTzDryrsLCmMs5zYEYpLx1zkGDmrJV8RK773HVoPjqMrV7W0eJiYVbYdFEzJaVUvBQioZd_0HnThVX6LlFKUSak2gaynrKhiTGg1-tQL0341BT0VqPuNeqkUX9r1Ju0dLGL7t6W6PYrP94SwHsgptFqhuH39j-xXx0_fJM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2666124565</pqid></control><display><type>article</type><title>Targeted therapies for cardiac diseases</title><source>Alma/SFX Local Collection</source><creator>Maack, Christoph ; Tardiff, Jil C.</creator><creatorcontrib>Maack, Christoph ; Tardiff, Jil C.</creatorcontrib><description>Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regulatory Mechanisms aims to identify novel treatment targets by applying high-resolution approaches to complex cardiac disorders.</description><identifier>ISSN: 1759-5002</identifier><identifier>ISSN: 1759-5010</identifier><identifier>EISSN: 1759-5010</identifier><identifier>DOI: 10.1038/s41569-022-00704-x</identifier><identifier>PMID: 35468998</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/420 ; 692/699/75/230 ; 692/700/565 ; Antineoplastic Agents - therapeutic use ; Cancer therapies ; Cardiac function ; Cardiac Imaging ; Cardiac Surgery ; Cardiology ; Cardiomyopathy ; Child development ; Comment ; Dehydrogenases ; Disease ; Ejection fraction ; Heart attacks ; Heart Diseases - drug therapy ; Heart failure ; Humans ; Immune system ; Inflammation ; Medicine ; Medicine &amp; Public Health ; Metabolic disorders ; Molecular Targeted Therapy ; Nervous system ; Obesity ; Physiology</subject><ispartof>Nature reviews cardiology, 2022-06, Vol.19 (6), p.343-344</ispartof><rights>Springer Nature Limited 2022</rights><rights>Springer Nature Limited 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53</citedby><cites>FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53</cites><orcidid>0000-0003-3694-4559</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35468998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maack, Christoph</creatorcontrib><creatorcontrib>Tardiff, Jil C.</creatorcontrib><title>Targeted therapies for cardiac diseases</title><title>Nature reviews cardiology</title><addtitle>Nat Rev Cardiol</addtitle><addtitle>Nat Rev Cardiol</addtitle><description>Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regulatory Mechanisms aims to identify novel treatment targets by applying high-resolution approaches to complex cardiac disorders.</description><subject>692/420</subject><subject>692/699/75/230</subject><subject>692/700/565</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Cancer therapies</subject><subject>Cardiac function</subject><subject>Cardiac Imaging</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Child development</subject><subject>Comment</subject><subject>Dehydrogenases</subject><subject>Disease</subject><subject>Ejection fraction</subject><subject>Heart attacks</subject><subject>Heart Diseases - drug therapy</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metabolic disorders</subject><subject>Molecular Targeted Therapy</subject><subject>Nervous system</subject><subject>Obesity</subject><subject>Physiology</subject><issn>1759-5002</issn><issn>1759-5010</issn><issn>1759-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhoMotlb_gAdZ8KCX1cnn7h6l-AUFL_UcYjKpW9puTXah_ntTt1bw4GkG5pl3hoeQcwo3FHh5GwWVqsqBsRygAJFvDsiQFrLKJVA43PfABuQkxjmAEoXkx2TApVBlVZVDcjU1YYYtuqx9x2DWNcbMNyGzJrja2MzVEU3EeEqOvFlEPNvVEXl9uJ-On_LJy-Pz-G6SW17INhcODXeytKAs5Qq5soqWhTElrRTzDryrsLCmMs5zYEYpLx1zkGDmrJV8RK773HVoPjqMrV7W0eJiYVbYdFEzJaVUvBQioZd_0HnThVX6LlFKUSak2gaynrKhiTGg1-tQL0341BT0VqPuNeqkUX9r1Ju0dLGL7t6W6PYrP94SwHsgptFqhuH39j-xXx0_fJM</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Maack, Christoph</creator><creator>Tardiff, Jil C.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3694-4559</orcidid></search><sort><creationdate>20220601</creationdate><title>Targeted therapies for cardiac diseases</title><author>Maack, Christoph ; Tardiff, Jil C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>692/420</topic><topic>692/699/75/230</topic><topic>692/700/565</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Cancer therapies</topic><topic>Cardiac function</topic><topic>Cardiac Imaging</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Child development</topic><topic>Comment</topic><topic>Dehydrogenases</topic><topic>Disease</topic><topic>Ejection fraction</topic><topic>Heart attacks</topic><topic>Heart Diseases - drug therapy</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metabolic disorders</topic><topic>Molecular Targeted Therapy</topic><topic>Nervous system</topic><topic>Obesity</topic><topic>Physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maack, Christoph</creatorcontrib><creatorcontrib>Tardiff, Jil C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maack, Christoph</au><au>Tardiff, Jil C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeted therapies for cardiac diseases</atitle><jtitle>Nature reviews cardiology</jtitle><stitle>Nat Rev Cardiol</stitle><addtitle>Nat Rev Cardiol</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>19</volume><issue>6</issue><spage>343</spage><epage>344</epage><pages>343-344</pages><issn>1759-5002</issn><issn>1759-5010</issn><eissn>1759-5010</eissn><abstract>Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regulatory Mechanisms aims to identify novel treatment targets by applying high-resolution approaches to complex cardiac disorders.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>35468998</pmid><doi>10.1038/s41569-022-00704-x</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-3694-4559</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1759-5002
ispartof Nature reviews cardiology, 2022-06, Vol.19 (6), p.343-344
issn 1759-5002
1759-5010
1759-5010
language eng
recordid cdi_proquest_miscellaneous_2655563844
source Alma/SFX Local Collection
subjects 692/420
692/699/75/230
692/700/565
Antineoplastic Agents - therapeutic use
Cancer therapies
Cardiac function
Cardiac Imaging
Cardiac Surgery
Cardiology
Cardiomyopathy
Child development
Comment
Dehydrogenases
Disease
Ejection fraction
Heart attacks
Heart Diseases - drug therapy
Heart failure
Humans
Immune system
Inflammation
Medicine
Medicine & Public Health
Metabolic disorders
Molecular Targeted Therapy
Nervous system
Obesity
Physiology
title Targeted therapies for cardiac diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T19%3A51%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeted%20therapies%20for%20cardiac%20diseases&rft.jtitle=Nature%20reviews%20cardiology&rft.au=Maack,%20Christoph&rft.date=2022-06-01&rft.volume=19&rft.issue=6&rft.spage=343&rft.epage=344&rft.pages=343-344&rft.issn=1759-5002&rft.eissn=1759-5010&rft_id=info:doi/10.1038/s41569-022-00704-x&rft_dat=%3Cproquest_cross%3E2666124565%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-4dea3d58c06c136e36c6187aa81962fd0fd9e7ca9adf302a66f5d2d0c132dcc53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2666124565&rft_id=info:pmid/35468998&rfr_iscdi=true